$SVA
SINOVAC BIOTECH LTD Stock $sva

$sva Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 20-F Financial Statement

#000095017023015997 Filed on May 01, 2023

Income Statement

Concept	2022 Q4	2022	2021 Q4
Revenue	$280.5M	$1.493B	$8.394B
YoY Change	-96.66%	-92.3%	2463.01%
Cost Of Revenue	$430.1M	$684.5M	$440.5M
YoY Change	-2.35%	-36.16%	912.54%
Gross Profit	-$149.6M	$808.3M	$7.953B
YoY Change	-101.88%	-95.58%	2701.48%
Gross Profit Margin	-53.35%	54.15%	94.75%
Selling, General & Admin	$671.1M	$823.5M	$432.0M
YoY Change	55.34%	38.61%	413.11%
% of Gross Profit		101.89%	5.43%
Research & Development	$257.7M	$442.1M	$101.1M
YoY Change	154.84%	185.16%	3645.52%
% of Gross Profit		54.7%	1.27%
Depreciation & Amortization	$78.84M	$153.8M	$68.85M
YoY Change	14.52%	77.15%	5637.08%
% of Gross Profit		19.03%	0.87%
Operating Expenses	$928.1M	$1.274B	$533.1M
YoY Change	74.08%	70.27%	513.5%
Operating Profit	-$1.078B	-$466.1M	$7.420B
YoY Change	-114.52%	-102.66%	3666.63%
Interest Expense	$106.2M	$189.6M	$70.45M
YoY Change	50.72%	90.06%	70350.0%
% of Operating Profit			0.95%
Other Income/Expense, Net	$72.29M	$301.8M	-$89.00M
YoY Change	-181.23%	-435.47%	-6457.07%
Pretax Income	-$901.2M	$25.24M	$7.401B
YoY Change	-112.18%	-99.86%	3630.36%
Income Tax	-$198.9M	-$62.89M	$1.534B
% Of Pretax Income		-249.2%	20.73%
Net Earnings	-$373.7M	$113.9M	$3.359B
YoY Change	-111.12%	-98.66%	2987.46%
Net Earnings / Revenue	-133.23%	7.63%	40.02%
Basic Earnings Per Share		$1.08
Diluted Earnings Per Share	-$3.76	$1.00	$29.47M
COMMON SHARES
Basic Shares Outstanding	99.50M	99.50M
Diluted Shares Outstanding		114.2M

Balance Sheet

Concept	2022 Q4	2022	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.31B	$11.31B	$13.42B
YoY Change	-15.67%	-15.67%	1040.47%
Cash & Equivalents	$4.278B	$4.278B	$11.61B
Short-Term Investments	$7.035B	$7.035B	$1.806B
Other Short-Term Assets	$23.50M	$23.50M	$171.9M
YoY Change	-86.33%	-86.33%	595.92%
Inventory	$180.7M	$180.7M	$375.5M
Prepaid Expenses
Receivables	$537.1M	$497.0M	$952.4M
Other Receivables	$72.37M	$112.5M	$0.00
Total Short-Term Assets	$12.13B	$12.13B	$14.92B
YoY Change	-18.7%	-18.7%	855.91%
LONG-TERM ASSETS
Property, Plant & Equipment	$993.8M	$1.052B	$1.019B
YoY Change	-2.44%	3.31%	258.44%
Goodwill
YoY Change
Intangibles	$9.699M		$1.480M
YoY Change	555.34%
Long-Term Investments	$661.4M	$661.4M	$655.8M
YoY Change	0.85%	0.85%
Other Assets	$2.798M	$264.7M	$157.1M
YoY Change	-98.22%	68.5%	183.53%
Total Long-Term Assets	$1.988B	$1.988B	$1.833B
YoY Change	8.46%	8.46%	437.56%
TOTAL ASSETS
Total Short-Term Assets	$12.13B	$12.13B	$14.92B
Total Long-Term Assets	$1.988B	$1.988B	$1.833B
Total Assets	$14.11B	$14.11B	$16.75B
YoY Change	-15.72%	-15.72%	780.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$905.9M	$19.83M	$1.021B
YoY Change	-11.24%	-66.16%	382.81%
Accrued Expenses	$242.5M	$250.3M	$10.39M
YoY Change	2235.37%	-53.39%	196.71%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$4.651M	$4.651M	$4.681M
YoY Change	-0.64%	-0.64%	-88.03%
Total Short-Term Liabilities	$1.092B	$1.092B	$2.413B
YoY Change	-54.76%	-54.76%	255.04%
LONG-TERM LIABILITIES
Long-Term Debt	$11.51M	$11.51M	$17.38M
YoY Change	-33.74%	-33.74%	109.35%
Other Long-Term Liabilities	$240.0K	$57.23M	$117.8M
YoY Change	-99.8%	-51.41%	30.0%
Total Long-Term Liabilities	$310.3M	$68.75M	$135.2M
YoY Change	129.57%	-49.14%	36.66%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.092B	$1.092B	$2.413B
Total Long-Term Liabilities	$310.3M	$68.75M	$135.2M
Total Liabilities	$1.402B	$5.193B	$7.421B
YoY Change	-81.11%	-30.02%	542.54%
SHAREHOLDERS EQUITY
Retained Earnings	$7.226B		$7.142B
YoY Change	1.18%
Common Stock	$540.7M		$547.8M
YoY Change	-1.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.921B	$8.921B	$9.327B
YoY Change
Total Liabilities & Shareholders Equity	$14.11B	$14.11B	$16.75B
YoY Change	-15.72%	-15.72%	780.88%

Cashflow Statement

Concept	2022 Q4	2022	2021 Q4
OPERATING ACTIVITIES
Net Income	-$373.7M	$113.9M	$3.359B
YoY Change	-111.12%	-98.66%	2987.46%
Depreciation, Depletion And Amortization	$78.84M	$153.8M	$68.85M
YoY Change	14.52%	77.15%	5637.08%
Cash From Operating Activities	$37.42M	-$770.7M	$6.265B
YoY Change	-99.4%	-105.02%	1202.31%
INVESTING ACTIVITIES
Capital Expenditures	$124.0M	$403.4M	-$288.5M
YoY Change	-142.97%	-156.03%	398.26%
Acquisitions
YoY Change
Other Investing Activities	-$2.052B	-$5.357B	$539.8M
YoY Change	-480.12%	132.55%	-672.43%
Cash From Investing Activities	-$2.176B	-$5.760B	$251.3M
YoY Change	-965.81%	90.52%	-265.12%
FINANCING ACTIVITIES
Cash Dividend Paid		$263.2M
YoY Change		-85.97%
Common Stock Issuance & Retirement, Net		$0.00	$996.0K
YoY Change		-100.0%	-50.2%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-253.1M	-241.4M	-1.867B
YoY Change	-86.44%	-87.27%	-444.6%
NET CHANGE
Cash From Operating Activities	37.42M	-770.7M	6.265B
Cash From Investing Activities	-2.176B	-5.760B	251.3M
Cash From Financing Activities	-253.1M	-241.4M	-1.867B
Net Change In Cash	-2.392B	-7.333B	4.650B
YoY Change	-151.43%	-170.3%	434.12%
FREE CASH FLOW
Cash From Operating Activities	$37.42M	-$770.7M	$6.265B
Capital Expenditures	$124.0M	$403.4M	-$288.5M
Free Cash Flow	-$86.55M	-$1.174B	$6.554B
YoY Change	-101.32%	-107.31%	1115.94%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022	dei	Entity Registrant Name EntityRegistrantName	SINOVAC BIOTECH LTD
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	No. 39 Shangdi Xi Road
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Haidian District
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Beijing
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	100085
CY2022	dei	Entity Address Country EntityAddressCountry	CN
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	99502243
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2022	dei	Entity Bankruptcy Proceedings Reporting Current EntityBankruptcyProceedingsReportingCurrent	false
CY2022	dei	Auditor Firm AuditorFirmId	1487
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	B9
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001084201
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022	dei	Document Type DocumentType	20-F
CY2022	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022	dei	Entity File Number EntityFileNumber	001-32371
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1267504000
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	17955000
CY2021	dei	Auditor Firm AuditorFirmId	5395
CY2022	dei	Auditor Name AuditorName	Grant Thornton Zhitong Certified Public Accountants LLP
CY2022	dei	Auditor Location AuditorLocation	Beijing, China
CY2021	dei	Auditor Name AuditorName	Marcum Asia CPAs LLP
CY2021	dei	Auditor Location AuditorLocation	Beijing, China
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4278124000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11608855000
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	8253000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	10905000
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	7034569000
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	1806449000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	537118000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	952402000
CY2022Q4	us-gaap	Inventory Net InventoryNet	180719000
CY2021Q4	us-gaap	Inventory Net InventoryNet	375511000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15242000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	160987000
CY2022Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	72371000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	12126396000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	14915109000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	993781000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	903298000
CY2022Q4	sva	Prepaid Land Lease Payments PrepaidLandLeasePayments	69815000
CY2021Q4	sva	Prepaid Land Lease Payments PrepaidLandLeasePayments	39730000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9699000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1480000
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	23000
CY2021Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	25000
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	661440000
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	655835000
CY2022Q4	sva	Prepayments For Acquisition Of Equipment Non Current PrepaymentsForAcquisitionOfEquipmentNonCurrent	120912000
CY2021Q4	sva	Prepayments For Acquisition Of Equipment Non Current PrepaymentsForAcquisitionOfEquipmentNonCurrent	65290000
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	71118000
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	52031000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	58586000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	115376000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2798000
CY2022Q4	us-gaap	Assets Assets	14114568000
CY2021Q4	us-gaap	Assets Assets	16748174000
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	293000
CY2021Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	3099000
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	4358000
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1582000
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	905923000
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1020651000
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	79941000
CY2022Q4	sva	Deferred Government Grants Current DeferredGovernmentGrantsCurrent	15120000
CY2021Q4	sva	Deferred Government Grants Current DeferredGovernmentGrantsCurrent	12559000
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	141993000
CY2021Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	17125000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5993000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	10385000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1091635000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2412846000
CY2022Q4	sva	Deferred Government Grants Noncurrent DeferredGovernmentGrantsNoncurrent	4477000
CY2021Q4	sva	Deferred Government Grants Noncurrent DeferredGovernmentGrantsNoncurrent	4870000
CY2022Q4	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	11513000
CY2021Q4	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	12668000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	241526000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	324164000
CY2021Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	4708000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	52516000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	112465000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	240000
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	444000
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	310272000
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	459319000
CY2022Q4	us-gaap	Liabilities Liabilities	1401907000
CY2021Q4	us-gaap	Liabilities Liabilities	2872165000
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	15000
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	15000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	14630813
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	14630813
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	14630813
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	14630813
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	100000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	100000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	99502243
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	99502243
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	99502243
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	99502243
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	540582000
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	547691000
CY2021Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	7109000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-383276000
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	130622000
CY2022Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	1538013000
CY2021Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	1514297000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	7225987000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	7141819000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	8921421000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	9327435000
CY2022Q4	us-gaap	Minority Interest MinorityInterest	3791240000
CY2021Q4	us-gaap	Minority Interest MinorityInterest	4548574000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12712661000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13876009000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14114568000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16748174000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1492761000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19374904000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	510624000
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	684456000
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	1072221000
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	67180000
CY2022	us-gaap	Gross Profit GrossProfit	808305000
CY2021	us-gaap	Gross Profit GrossProfit	18302683000
CY2020	us-gaap	Gross Profit GrossProfit	443444000
CY2022	sva	Rent Expenses Incurred To Related Party RentExpensesIncurredToRelatedParty	819000
CY2021	sva	Rent Expenses Incurred To Related Party RentExpensesIncurredToRelatedParty	851000
CY2020	sva	Rent Expenses Incurred To Related Party RentExpensesIncurredToRelatedParty	798000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	823543000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	591167000
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	176534000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4268000
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2967000
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2640000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	442108000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	155040000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	48760000
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-5213000
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-977000
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-163000
CY2022	sva	Government Grants Recognized In Income GovernmentGrantsRecognizedInIncome	760000
CY2021	sva	Government Grants Recognized In Income GovernmentGrantsRecognizedInIncome	725000
CY2020	sva	Government Grants Recognized In Income GovernmentGrantsRecognizedInIncome	297000
CY2022	us-gaap	Operating Expenses OperatingExpenses	1274372000
CY2021	us-gaap	Operating Expenses OperatingExpenses	749426000
CY2020	us-gaap	Operating Expenses OperatingExpenses	227800000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-466067000
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	6073832000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	17553257000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	215644000
CY2022	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	354000
CY2021	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	916000
CY2020	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	663000
CY2022	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1264000
CY2021	us-gaap	Interest And Debt Expense InterestAndDebtExpense	2836000
CY2020	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1453000
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	190818000
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	102568000
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	1930000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	301751000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-89948000
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	496000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	25238000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	17563041000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	216617000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-62893000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3104130000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31438000
CY2022	us-gaap	Profit Loss ProfitLoss	88131000
CY2021	us-gaap	Profit Loss ProfitLoss	14458911000
CY2020	us-gaap	Profit Loss ProfitLoss	185179000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-25735000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	5991431000
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	74810000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	113866000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	8467480000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	110369000
CY2022	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	5982000
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	5982000
CY2020	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	6015000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	107884000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	8461498000
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	104354000
CY2022	us-gaap	Profit Loss ProfitLoss	88131000
CY2021	us-gaap	Profit Loss ProfitLoss	14458911000
CY2020	us-gaap	Profit Loss ProfitLoss	185179000
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-859045000
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	193098000
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	32328000
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-770914000
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	14652009000
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	217507000
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-370882000
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	82892000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-400032000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8578177000
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	134615000
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.08
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	85.20
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.06
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.00
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	74.27
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.97
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99502243
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99311551
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	98897345
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	114172782
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	114005983
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	113662362
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	352195000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10203000
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	13999000
CY2020	sva	Adjustments To Additional Paid In Capital Share Based Compensation Subscriptions Receivable AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationSubscriptionsReceivable	12000000
CY2020	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0
CY2020	sva	Equity Transactions Of Subsidiaries EquityTransactionsOfSubsidiaries	544236000
CY2020	us-gaap	Dividends Dividends	6015000
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	8082000
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	24246000
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	74810000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	110369000
CY2020	sva	Transfer To Statutory Surplus Reserves TransferToStatutorySurplusReserves	0
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1120125000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1120125000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7735000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1033000
CY2021	us-gaap	Dividends Dividends	1904893000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	82401000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	110697000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	5991431000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	8467480000
CY2021	sva	Transfer To Statutory Surplus Reserves TransferToStatutorySurplusReserves	0
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13876009000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13876009000
CY2022	sva	Adjustments To Additional Paid In Capital Share Based Compensation Subscriptions Receivable AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationSubscriptionsReceivable	0
CY2022	us-gaap	Dividends Dividends	392434000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-345147000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-513898000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-25735000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	113866000
CY2022	sva	Transfer To Statutory Surplus Reserves TransferToStatutorySurplusReserves	0
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12712661000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	720858000
CY2022	us-gaap	Profit Loss ProfitLoss	88131000
CY2021	us-gaap	Profit Loss ProfitLoss	14458911000
CY2020	us-gaap	Profit Loss ProfitLoss	185179000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-83010000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	265096000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-11227000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	0
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	7735000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	10203000
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	140004000
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	70133000
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	5816000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4268000
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2967000
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2640000
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-5213000
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-977000
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-163000
CY2022	us-gaap	Depreciation Depreciation	153819000
CY2021	us-gaap	Depreciation Depreciation	84446000
CY2020	us-gaap	Depreciation Depreciation	3693000
CY2022	sva	Amortization Of Land Use Right AmortizationOfLandUseRight	1749000
CY2021	sva	Amortization Of Land Use Right AmortizationOfLandUseRight	2203000
CY2020	sva	Amortization Of Land Use Right AmortizationOfLandUseRight	238000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1029000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	183000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	106000
CY2022	sva	Government Grants Recognized In Income GovernmentGrantsRecognizedInIncome	760000
CY2021	sva	Government Grants Recognized In Income GovernmentGrantsRecognizedInIncome	725000
CY2020	sva	Government Grants Recognized In Income GovernmentGrantsRecognizedInIncome	297000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-289600000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	710355000
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	128016000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-30382000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	334062000
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	77738000
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1275296000
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1216717000
CY2020	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	31804000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-22519000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	143324000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	13151000
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-58485000
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-288779000
CY2020	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	339329000
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-86860000
CY2022	us-gaap	Payments To Acquire Lease Receivables PaymentsToAcquireLeaseReceivables	35683000
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	131777000
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-3048000
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-440000
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-1210000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-770745000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	15352541000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	479309000
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	151000
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	13511000
CY2020	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	33227000
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	2981000
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	33436000
CY2020	us-gaap	Repayments Of Debt RepaymentsOfDebt	6041000
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1033000
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1999000
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	263171000
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	1875892000
CY2020	us-gaap	Payments Of Dividends PaymentsOfDividends	0
CY2022	sva	Proceeds From Subsidiaries Financing ProceedsFromSubsidiariesFinancing	11291000
CY2021	sva	Proceeds From Subsidiaries Financing ProceedsFromSubsidiariesFinancing	0
CY2020	sva	Proceeds From Subsidiaries Financing ProceedsFromSubsidiariesFinancing	541043000
CY2022	sva	Proceeds From Government Grants ProceedsFromGovernmentGrants	14797000
CY2021	sva	Proceeds From Government Grants ProceedsFromGovernmentGrants	4317000
CY2020	sva	Proceeds From Government Grants ProceedsFromGovernmentGrants	16521000
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	7119000
CY2020	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	10162000
CY2022	sva	Repayments Of Loan From Noncontrolling Shareholder RepaymentsOfLoanFromNoncontrollingShareholder	1486000
CY2021	sva	Repayments Of Loan From Noncontrolling Shareholder RepaymentsOfLoanFromNoncontrollingShareholder	13332000
CY2020	sva	Repayments Of Loan From Noncontrolling Shareholder RepaymentsOfLoanFromNoncontrollingShareholder	4345000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-241399000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1896680000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	592566000
CY2022	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	6327521000
CY2021	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	6567491000
CY2020	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	124562000
CY2022	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	114352000
CY2021	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	0
CY2020	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	0
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	608000
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	172000
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	20000
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	9568000
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	154000
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	164000
CY2021	us-gaap	Payments To Acquire Lease Receivables PaymentsToAcquireLeaseReceivables	30986000
CY2020	us-gaap	Payments To Acquire Lease Receivables PaymentsToAcquireLeaseReceivables	0
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	2915000
CY2022	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	11658465000
CY2021	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	8826611000
CY2020	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	201688000
CY2022	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	393800000
CY2021	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	719823000
CY2020	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	127486000
CY2022	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	105435000
CY2021	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	13663000
CY2020	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	0
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5760470000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3023574000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-204756000
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-560769000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	137269000
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27207000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7333383000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	10569556000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	894326000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11619760000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1050204000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	155878000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4286377000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11619760000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1050204000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	1112000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	2799000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	1041000
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	1321563000
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	1487979000
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	11172000
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">(a) Use of Estimates</span></p><p style="margin-left:10.0%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">In preparation of the Company’s consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant estimates made by management include provision for product returns, allowance for doubtful accounts, inventory provisions, impairment of long-lived assets, fair value of options granted and related forfeiture rates, and realizability of deferred tax assets. On an ongoing basis, management reviews its estimates to ensure that these estimates appropriately reflect changes in the Company’s business and new information as it becomes available. If historical experience and other factors used by management to make these estimates do not reasonably reflect future activity, the Company’s consolidated financial statements could be materially impacted.</span></p>
CY2022Q4	sva	Long Term Debt Maturities Repayments Of Principal After Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour	4809000
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	11806000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4286377000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11619760000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1050204000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4278124000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11608855000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1041008000
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	8253000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	10905000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9196000
CY2022Q4	us-gaap	Short Term Debt Weighted Average Interest Rate ShortTermDebtWeightedAverageInterestRate	0.0588
CY2021Q4	us-gaap	Short Term Debt Weighted Average Interest Rate ShortTermDebtWeightedAverageInterestRate	0.0465
CY2022Q4	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	17719000
CY2021Q4	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	33749000
CY2022	sva	Percentage Of Sales Return Provision PercentageOfSalesReturnProvision	0.012
CY2021	sva	Percentage Of Sales Return Provision PercentageOfSalesReturnProvision	0.002
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	54494000
CY2022	us-gaap	Advertising Expense AdvertisingExpense	6010000
CY2021	us-gaap	Advertising Expense AdvertisingExpense	7688000
CY2020	us-gaap	Advertising Expense AdvertisingExpense	859000
CY2020Q4	us-gaap	Short Term Debt Weighted Average Interest Rate ShortTermDebtWeightedAverageInterestRate	0.0477
CY2022	us-gaap	Interest Costs Incurred InterestCostsIncurred	1264000
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	31247000
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	18243000
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	10809000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	265091000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-68026000
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2554000
CY2021	us-gaap	Interest Costs Incurred InterestCostsIncurred	3023000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	265091000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-68026000
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2554000
CY2022Q4	sva	Cash And Cash Equivalents At Carrying Value Denominated In Rmb CashAndCashEquivalentsAtCarryingValueDenominatedInRMB	1490336000
CY2022Q4	sva	Cash And Cash Equivalents At Carrying Value Denominated In Rmb CashAndCashEquivalentsAtCarryingValueDenominatedInRMB	10279000000
CY2021Q4	sva	Cash And Cash Equivalents At Carrying Value Denominated In Rmb CashAndCashEquivalentsAtCarryingValueDenominatedInRMB	7220296000
CY2021Q4	sva	Cash And Cash Equivalents At Carrying Value Denominated In Rmb CashAndCashEquivalentsAtCarryingValueDenominatedInRMB	46012000000
CY2020	us-gaap	Interest Costs Incurred InterestCostsIncurred	1485000
CY2022	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	0
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	8253000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	10905000
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	8253000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	10905000
CY2022Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	7034569000
CY2021Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	1806449000
CY2022Q4	us-gaap	Debt Securities DebtSecurities	537500000
CY2021Q4	us-gaap	Debt Securities DebtSecurities	642004000
CY2022Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	123940000
CY2021Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	13831000
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	661440000
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	655835000
CY2021	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	187000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	537118000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	952402000
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	88021000
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	111713000
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	45976000
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	142935000
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	46722000
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	120863000
CY2022Q4	us-gaap	Inventory Net InventoryNet	180719000
CY2021Q4	us-gaap	Inventory Net InventoryNet	375511000
CY2022	sva	Fixed Production Overhead To Cost Of Sales FixedProductionOverheadToCostOfSales	97514000
CY2021	sva	Fixed Production Overhead To Cost Of Sales FixedProductionOverheadToCostOfSales	8582000
CY2020	sva	Fixed Production Overhead To Cost Of Sales FixedProductionOverheadToCostOfSales	1697000
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	140004000
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	70133000
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	5816000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1258827000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1043748000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	265046000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	140450000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	993781000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	903298000
CY2022	us-gaap	Depreciation Depreciation	153819000
CY2021	us-gaap	Depreciation Depreciation	84446000
CY2020	us-gaap	Depreciation Depreciation	3693000
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-5213000
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-977000
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-163000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1457000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1029000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	183000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	106000
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.049
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	9102000
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	3158000
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1464000
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	784000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	2332000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	13992000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	14067000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	50611000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	10926000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	11088000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	9136000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	9193000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	9554000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	46915000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	96812000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	38303000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	58509000
CY2022	us-gaap	Short Term Lease Payments ShortTermLeasePayments	13000
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	293000
CY2021Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	3099000
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	11513000
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	12668000
CY2022Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	11806000
CY2021Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	15767000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	293000
CY2020	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	32000
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	4358000
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1582000
CY2021Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	4708000
CY2022Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	4358000
CY2021Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	6290000
CY2022	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	3521000
CY2021	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	851000
CY2020	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	798000
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	19825000
CY2021Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	58590000
CY2022Q4	sva	Capital Expenditures Incurred But Not Yet Paid Machinery And Equipment CapitalExpendituresIncurredButNotYetPaidMachineryAndEquipment	67475000
CY2021Q4	sva	Capital Expenditures Incurred But Not Yet Paid Machinery And Equipment CapitalExpendituresIncurredButNotYetPaidMachineryAndEquipment	84728000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	242528000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	508549000
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1784000
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	18068000
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	254302000
CY2021Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	9800000
CY2022Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	554000
CY2021Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	6718000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	311440000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	323247000
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	8015000
CY2021Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	10951000
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	905923000
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1020651000
CY2008	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	48500000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	94372000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	5866000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-23262000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	17468669000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	210751000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	25238000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	17563041000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	216617000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	20117000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2839034000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	42665000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-83010000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	265096000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-11227000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-62893000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3104130000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31438000
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	12707000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4254000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	25238000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	17563041000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	216617000
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-6310000
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4390760000
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-54154000
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	1665000
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-5303000
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	419000
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	84008000
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	159235000
CY2020	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	7229000
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	55748000
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	227821000
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	2225000
CY2022	sva	Income Tax Reconciliation Effect Of Preferential Tax Treatment IncomeTaxReconciliationEffectOfPreferentialTaxTreatment	-4213000
CY2021	sva	Income Tax Reconciliation Effect Of Preferential Tax Treatment IncomeTaxReconciliationEffectOfPreferentialTaxTreatment	1774595000
CY2020	sva	Income Tax Reconciliation Effect Of Preferential Tax Treatment IncomeTaxReconciliationEffectOfPreferentialTaxTreatment	19224000
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	12707000
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4135000
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-2656000
CY2022	sva	Income Tax Reconciliation Effect Of Withholding Tax On Distributable Profits Of Subsidiaries IncomeTaxReconciliationEffectOfWithholdingTaxOnDistributableProfitsOfSubsidiaries	-59006000
CY2021	sva	Income Tax Reconciliation Effect Of Withholding Tax On Distributable Profits Of Subsidiaries IncomeTaxReconciliationEffectOfWithholdingTaxOnDistributableProfitsOfSubsidiaries	426737000
CY2020	sva	Income Tax Reconciliation Effect Of Withholding Tax On Distributable Profits Of Subsidiaries IncomeTaxReconciliationEffectOfWithholdingTaxOnDistributableProfitsOfSubsidiaries	2747000
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	522000
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	6190000
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-1002000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-62893000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3104130000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31438000
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	16573000
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	6794000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	64283000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	56309000
CY2022Q4	sva	Deferred Tax Assets Tax Deferred Expense Government Grants Current DeferredTaxAssetsTaxDeferredExpenseGovernmentGrantsCurrent	2935000
CY2021Q4	sva	Deferred Tax Assets Tax Deferred Expense Government Grants Current DeferredTaxAssetsTaxDeferredExpenseGovernmentGrantsCurrent	2589000
CY2022Q4	sva	Deferred Tax Assets Fixed Assets DeferredTaxAssetsFixedAssets	-12673000
CY2021Q4	sva	Deferred Tax Assets Fixed Assets DeferredTaxAssetsFixedAssets	-13661000
CY2022Q4	sva	Deferred Tax Assets Operating Loss Carry Forwards Noncurrent DeferredTaxAssetsOperatingLossCarryForwardsNoncurrent	16961000
CY2021Q4	sva	Deferred Tax Assets Operating Loss Carry Forwards Noncurrent DeferredTaxAssetsOperatingLossCarryForwardsNoncurrent	4254000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16961000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4254000
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	71118000
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	52031000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16961000
CY2022Q4	sva	Deferred Tax Liabilities Represents Withholding Tax DeferredTaxLiabilitiesRepresentsWithholdingTax	209516000
CY2022	sva	Withholding Tax Rate WithholdingTaxRate	0.05
CY2022	sva	Withholding Tax Rate Before Treaty Benefits WithholdingTaxRateBeforeTreatyBenefits	0.10
CY2022	sva	Withholding Tax Rate After Treaty Benefits WithholdingTaxRateAfterTreatyBenefits	0.05
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	275000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	561000
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	904000
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	194000
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	286000
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	343000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	81000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	275000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	561000
CY2022	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	106000
CY2021	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	135000
CY2020	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	107000
CY2022Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	64000
CY2021Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	170000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	81000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	275000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	561000
CY2022Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	81000
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	275000
CY2020Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	561000
CY2022	sva	Proceeds From Government Grants Received ProceedsFromGovernmentGrantsReceived	6984000
CY2021	sva	Proceeds From Government Grants Received ProceedsFromGovernmentGrantsReceived	2660000
CY2020	sva	Proceeds From Government Grants Received ProceedsFromGovernmentGrantsReceived	14162000
CY2022Q4	sva	Deferred Government Grants Current DeferredGovernmentGrantsCurrent	15120000
CY2021Q4	sva	Deferred Government Grants Current DeferredGovernmentGrantsCurrent	12559000
CY2022Q4	sva	Deferred Government Grants Noncurrent DeferredGovernmentGrantsNoncurrent	4477000
CY2021Q4	sva	Deferred Government Grants Noncurrent DeferredGovernmentGrantsNoncurrent	4870000
CY2022Q4	sva	Deferred Government Grants Current And Noncurrent DeferredGovernmentGrantsCurrentAndNoncurrent	19597000
CY2021Q4	sva	Deferred Government Grants Current And Noncurrent DeferredGovernmentGrantsCurrentAndNoncurrent	17429000
CY2021Q4	sva	Restricted Paid In Capital Additional Paid In Capital And Statutory Surplus Reserves RestrictedPaidInCapitalAdditionalPaidInCapitalAndStatutorySurplusReserves	1906482000
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P0Y3M29D
CY2022Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	4.98
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7735000
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	14630813
CY2022	sva	Common Stock Vote Per Share CommonStockVotePerShare	1
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	99502243
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	99502243
CY2018Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	2000000
CY2018Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	172500
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.98
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	257025
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	172500
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.98
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	257025
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	172500
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	4.98
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	-257025
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	172500
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.98
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	257025
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	172500
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P0Y3M29D
CY2022Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	4.98
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	172500
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10203000
CY2022	sva	Appropriation Of Net Income After Taxes To Statutory Surplus Reserve Fund Required Minimum Percentage AppropriationOfNetIncomeAfterTaxesToStatutorySurplusReserveFundRequiredMinimumPercentage	0.10
CY2022	sva	Reserve Level Threshold For Mandatory Transfer Percentage ReserveLevelThresholdForMandatoryTransferPercentage	0.50
CY2022Q4	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	1538013000
CY2021Q4	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	514297000
CY2022Q4	sva	Restricted Paid In Capital Additional Paid In Capital And Statutory Surplus Reserves RestrictedPaidInCapitalAdditionalPaidInCapitalAndStatutorySurplusReserves	1930199000
CY2022Q4	sva	Restricted Paid In Capital Additional Paid In Capital And Statutory Surplus Reserves RestrictedPaidInCapitalAdditionalPaidInCapitalAndStatutorySurplusReserves	12640000000
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	0
CY2021Q4	sva	Restricted Paid In Capital Additional Paid In Capital And Statutory Surplus Reserves RestrictedPaidInCapitalAdditionalPaidInCapitalAndStatutorySurplusReserves	12390000000
CY2022Q4	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	5873741000
CY2021Q4	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	8512960000
CY2022	us-gaap	Profit Loss ProfitLoss	88131000
CY2021	us-gaap	Profit Loss ProfitLoss	14458911000
CY2020	us-gaap	Profit Loss ProfitLoss	185179000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-25735000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	5991431000
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	74810000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	113866000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	8467480000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	110369000
CY2022	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	5982000
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	5982000
CY2020	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	6015000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	107884000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	8461498000
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	104354000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	113866000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	8467480000
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	110369000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99502243
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99311551
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	98897345
CY2022	sva	Incremental Common Shares Attributable To Share Based Payment Arrangements And Preferred Shares IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsAndPreferredShares	14670539
CY2021	sva	Incremental Common Shares Attributable To Share Based Payment Arrangements And Preferred Shares IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsAndPreferredShares	14694432
CY2020	sva	Incremental Common Shares Attributable To Share Based Payment Arrangements And Preferred Shares IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsAndPreferredShares	14765017
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	114172782
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	114005983
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	113662362
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.08
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	85.20
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.06
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.00
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	74.27
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.97
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	1063596
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	943028
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	0
CY2020	sva	Milestone Fee Recorded Research And Development Expenses MilestoneFeeRecordedResearchAndDevelopmentExpenses	35000
CY2020	sva	Milestone Fee Recorded Research And Development Expenses MilestoneFeeRecordedResearchAndDevelopmentExpenses	30000
CY2022Q4	us-gaap	Assets Assets	14114568000
CY2021Q4	us-gaap	Assets Assets	16748174000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1492761000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19374904000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	510624000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1492761000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19374904000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	510624000
CY2020Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	0
CY2021Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	0
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	0
CY2022	sva	Milestone Fee Recorded Cost Of Goods Sold MilestoneFeeRecordedCostOfGoodsSold	68000
CY2022	sva	Milestone Fee Recorded Cost Of Goods Sold MilestoneFeeRecordedCostOfGoodsSold	60000
CY2021	sva	Milestone Fee Recorded Cost Of Goods Sold MilestoneFeeRecordedCostOfGoodsSold	72000
CY2021	sva	Milestone Fee Recorded Cost Of Goods Sold MilestoneFeeRecordedCostOfGoodsSold	60000
CY2020	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	0

Files In Submission

Name	View Source	Status
0000950170-23-015997-index-headers.html	Edgar Link	pending
0000950170-23-015997-index.html	Edgar Link	pending
0000950170-23-015997.txt	Edgar Link	pending
0000950170-23-015997-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img56810700_0.jpg	Edgar Link	pending
img56810700_1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sva-20221231.htm	Edgar Link	pending
sva-20221231.xsd	Edgar Link	pending
sva-ex12_1.htm	Edgar Link	pending
sva-ex12_2.htm	Edgar Link	pending
sva-ex13_1.htm	Edgar Link	pending
sva-ex13_2.htm	Edgar Link	pending
sva-ex15_1.htm	Edgar Link	pending
sva-ex15_2.htm	Edgar Link	pending
sva-ex8_1.htm	Edgar Link	pending
sva-20221231_cal.xml	Edgar Link	unprocessable
sva-20221231_def.xml	Edgar Link	unprocessable
sva-20221231_lab.xml	Edgar Link	unprocessable
sva-20221231_pre.xml	Edgar Link	unprocessable
sva-20221231_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SVA
SINOVAC BIOTECH LTD Stock $sva

2022 Q4 Form 20-F Financial Statement

#000095017023015997 Filed on May 01, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SVA SINOVAC BIOTECH LTD Stock $sva

2022 Q4 Form 20-F Financial Statement

#000095017023015997 Filed on May 01, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SVA
SINOVAC BIOTECH LTD Stock $sva